Company news_innoModel-Provide preclinical pharmacological services

Cn /En

News Center

——

Company news

Industry news

06-28

InnoModels Biotechnology Luminex Platform: A New Driving Force for Drug Development

In the vast world of pharmaceutical R&D, technological innovation is the core driving force for scientific progress. By virtue of its Luminex platform, InnoModels Biotechnology has demonstrated significant advantages in the field of drug discovery and development, providing strong technical support for new drug discovery and development. In this article, we will introduce the advantages of Luminex platform and discuss its important role in drug discovery.

06-27

InnoModels Biotechnology FACS Platform: A Comprehensive Analysis of Features and Advantages

With the rapid development of biotechnology, Flow Cytometry Analysis Sorting (FACS) technology has become an important and indispensable tool in cell research and immunology. With its unique FACS platform, InnoModels Biotechnology (Beijing) Co., Ltd. stands out in the industry, providing researchers with efficient and accurate cell analysis solutions. In this article, we will introduce the features and advantages of the FACS platform of InnoModels Biotechnology in detail.

06-26

InnoModels Biotechnology ELISA Platform: Opening a New Era of Efficient and Accurate Biological Detection

In the field of biotechnology, enzyme-linked immunosorbent assay (ELISA), as a highly efficient assay, plays a crucial role in the observation of reactivity between biologically active ligands. However, the results of ELISA assay are affected by various factors, such as sensitivity, specificity, precision and stability. In order to provide a more reliable and efficient ELISA service, InnoModels Biotechnology has developed an ELISA platform, which has demonstrated significant value in the field of scientific research and clinical diagnostics due to its unique advantages.

06-25

InnoModels Biotechnology ELISpot Platform: Unique Advantages of Leading Immune Response Analysis

Immune response analysis plays a pivotal role in the broad field of life science research. Especially in cancer immunotherapy, vaccine development and infectious disease research, accurate analysis of cytotoxic T-lymphocytes (CTLs) and their immune responses is crucial. With its advanced ELISpot platform, InnoModels Biotechnology provides researchers with a powerful and reliable experimental tool, and its unique advantages are well recognized in the industry.

< 1...15 16 17...61 >

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License